News and Publications

2018 News

Gayathri Devi, PhD Speaks at Union Baptist Church to Increase Awareness of IBC

Brenda Denzler (IBC survivor) has Article Published on CURE (Cancer Updates, Research and Education) Website

Abstracts from Duke Breast Surgery Team Accepted at SSO Annual Meeting

Duke Predoctoral Student Receives Environmental Health Scholars Award

First Female Chief of Breast Surgery at Duke Named One of Time’s ‘Most Influential Americans’

Gayathri Devi, PhD, Presents at the Annual Geographical Management of Cancer Health Disparities Symposium

McDonnell Named Komen Scholar, Joins Board

Undergraduate Students in the Cell Death Laboratory Receive Honors

 

2019 Publications

Devi GR, Hough H, Barrett N, Cristofanilli M, Overmoyer B, Spector N, Ueno NT, Woodward W, Kirkpatrick J, Vincent B, Williams KP, Finley C, Duff B, Worthy V, McCall S, Hollister BA, Palmer G, Force J, Westbrook K, Fayanju O, Suneja G, Dent SF, Hwang ES, Patierno SR, Marcom PK. Perspectives on inflammatory breast cancer (IBC) research, clinical management and community engagement from the Duke IBC Consortium. Journal of Cancer. 2019; Jun 4; 10(15): 3344-3351.

Bocci F, Gearhart-Serna L, Boareto M, Ribeiro M, Ben-Jacob, Devi GR, Levine H, Onuchic JN, Jolly MK. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment. Proceedings of the National Academy of Sciences. 2019; Jan 2; 116(1):148-157.

Force J, Leal JHS, McArthur HL. Checkpoint blockade strategies in the treatment of breast cancer: Where we are and where we are heading. Current Treatment Options in Oncology. 2019; Mar 28;20(4):35.

Fayanju OM, Yenokyan K, Ren Y, Goldstein BA, Stashko I, Power S, Thornton MJ, Marcom PK, Hwang ESThe effect of treatment on patient-reported distress after breast cancer diagnosis. 2019; Sep 1;125(17):3040-3049. 

Bellon JR, Guo H, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, et al. Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Research and Treatment. 2019; Jul;176(2):303-310.

Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, Hyslop T, Peppercorn J, Wheeler SB, Zafar SY, Myers ER, Hwang ES. Financial costs and burden related to decisions for breast cancer surgery. Journal of Oncology Practice. 2019; Aug 15;15(8):e666-e676. 

Greenup RA, Rushing CN, Fish LJ, Lane WO, Peppercorn JM, Bellavance E, Tolnitch L, Hyslop T, Myers ER, Zafar SY, Hwang ES. Perspectives on the costs of cancer care: A survey of the American Society of Breast Surgeons. Annals of Surgical Oncology. 2019; Jul 24. 10.1245/s10434-019-07594-3.

Moorman PG, Barrett NJ, Wang F, Alberg JA, Bandera EV, Barnholtz-Sloan JB, Bondy M, Cote ML, Funkhouser E, Kelemen LE, Peres LC, Peters ES, Schwartz AG, Terry PD, Crankshaw S, Abbott SE, Schildkraut JMEffect of cultural, folk, and religious beliefs and practices on delays in diagnosis of ovarian cancer in African American Women. Journal of Womens Health. 2019; Apr; 28(4);444-451.

 

2018 Publications

Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. Survivorship and advocacy in inflammatory breast cancer. Journal of Cancer. 2018; 9(8):1430-1436.

Evans MK, Brown MC, Geradts J, Bao X, Robinston TJ, Jolly MK, Vermeulen PB, Palmer GM, Gromeier M, Levine H, Morse MA, Vanlaere SJ, Devi GR. XIAP regulation by MNK links MAPK and NFkB signaling to determine an aggressive breast cancer phenotype. Cancer Research. 2018;78(7):1726-1738. 

Fayanju OM, Park KU, Lucci A. Molecular genomic testing for breast cancer: Utility for surgeons. Annals of Surgical Oncology. 2018; Feb;25(2):512-519.

Force J, Howie LJ, Abbott SE, Bentley R, Marcom PK, Kimmick G, Westbrook K, Sammons SL, Parks M, Topping DL, Emerson R, Broadwater G, Hyslop T, Blackwell KL, Nair SK. Early stage HER2-positive breast cancers not achieving a pCR from neoadjuvant Trastuzumab- or Pertuzumab-based regimens have an immunosuppressive phenotype. Clinical Breast Cancer. 2018;2; pii: S1526-8209(17)30266-5.

Greenup RA, Obeng-Gyasi S, Thomas S, Houck K, Lane WO, Blitzblau RC, Hyslop T, Hwang ES. The effect of hospital volume on breast cancer mortality. Annals of Surgery. 2018; Feb 1;267(2):375-381. 

Han HS, Dieras V, Robson M, Palacova M, Marcom PK, Jager A, Bondarenko I, Citrin D, Campone M, Telli ML, Domchek SM, Friedlander M, Kaufman B, Garber JE, Shparyk Y, Chmielowska E, Jakobsen EH, Kaklamani V, Gradishar W, Ratajczak CK, Nickner C, Qin Q, Qian J, Shepherd SP, Isakoff SJ, Puhulla S. Veliparib wiht temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: Randomized Phase II study. Annals of Oncology. 2018; Jan 1;29(1):154-161.

Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: A multi-institutional study. JAMA Surgery. 2018; Feb 1;153(2):123-129.

Landercasper J, Fayanju OM, Bailey L, Berry TS, Borgert AJ, Buras R, Chen SL, Degnim AC, Froman J, Gass J, Greenberg C, Mautner SK, Krontiras H, Ramirez LD, Snowden M, Wexelman B, Wilke L, Rao R. Benchmarking the American Society of Breast Surgeon member performance for more than a million quality measure-patient encounters. Annals of Surgical Oncology. 2018; Feb;25(2):501-511.